Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?

The Invesco S&P 500 Pure Value ETF (RPV), a smart beta ETF with $1.33 billion AUM, seeks to track the S&P 500 Pure Value Index and has returned 3.22% YTD and 13.26% over the past year; the fund's largest sector allocation is Healthcare at 19.1%, with CVS Health Corp being the top holding at 3.43%. RPV's expense ratio is 0.35% and its 12-month trailing dividend yield is 2.26%, while alternative ETFs like SCHD and VTV offer lower expense ratios for investors seeking cheaper options in the large-cap value space.

Analysis

The Invesco S&P 500 Pure Value ETF (RPV), a smart beta fund launched on March 1, 2006, has accumulated over $1.33 billion in assets under management, positioning it as an average-sized ETF within the Style Box - Large Cap Value category. The fund aims to replicate the performance of the S&P 500 Pure Value Index, which targets S&P 500 securities exhibiting strong value characteristics. RPV carries an annual operating expense ratio of 0.35%, which is comparable to its peers, and offers a 12-month trailing dividend yield of 2.26%. Performance-wise, RPV has registered a year-to-date return of 3.22% and a 13.26% gain over the past year as of June 20, 2025, trading within a 52-week range of $81.66 to $97.21. The ETF's risk profile is characterized by a beta of 0.94 and a standard deviation of 18.05% over the trailing three-year period, indicating a medium risk level. Diversification is achieved through approximately 108 holdings, with the top 10 holdings constituting 23.66% of total assets. Sector-wise, Healthcare leads with a 19.1% allocation, followed by Consumer Staples and Financials; key individual holdings include CVS Health Corp (3.43%), Centene Corp, and Ford Motor Co. While RPV offers a targeted approach to value investing, alternative ETFs such as the Schwab U.S. Dividend Equity ETF (SCHD) and the Vanguard Value ETF (VTV) present significantly lower expense ratios of 0.06% and 0.04% respectively, alongside substantially larger asset bases.

Key Decisions for Investors

• Investors seeking dedicated exposure to S&P 500 'pure value' stocks may find RPV suitable, given its specific index tracking and recent positive performance, but should note its medium risk profile as indicated by its beta and standard deviation.